FindTrial
Sign In

The effect and safety of endoscopic mucosal resection (EMR) /endoscopic submucosal dissection (ESD)for early esophageal cancer

The effect and safety of endoscopic mucosal resection (EMR) /endoscopic submucosal dissection (ESD)for early esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17014231
Enrollment
Unknown
Registered
2017-12-30
Start date
2017-12-31
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early esophageal cancer

Interventions

Case series:EMR/ESD

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Above 18 years old; 2. Diagnosed as esophageal high-grade dysplasia or early esophageal cancer by endoscopy and pathology, as well as it meets the indications of endoscopic treatment.

Exclusion criteria

Exclusion criteria: 1. With serious diseases of important organs; 2. With serious psychiatric illness; 3. With lymph node metastasis or distant metastasis; 4. With malignant tumors of other system; 5. Not want to participate in the study.

Design outcomes

Primary

MeasureTime frame
The efficiency of endoscopic resection in patients with early esophageal cancer and esophageal high-grade dysplasia;The incidence of postoperative complications in patients with early esophageal cancer and esophageal high-grade dysplasia after endoscopic treatment;Tumor recurrence rate in 5 years;5-year survival rate;—

Secondary

MeasureTime frame
The risk factors of endoscopic treatment for postoperative complications;—

Countries

China

Contacts

Public ContactPeng Li

Beijing Friendship Hospital, Capital Medical University

lipeng@ccmu.edu.cn+86 13521136454

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026